IL6 and Parkinson disease: A high dose of PD treatment downregulated the expression of IL-6 (2.03 ± 0.21), TP53 (2.08 ± 0.54), and MAPK1 (1.66 ± 0.34) in the VIN+HPD group (P < 0.05).